R-CHOP + acalabrutinib clinical trials

Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL)

This study is testing if adding a new drug, acalabrutinib, to standard chemotherapy (R-CHOP) helps people with a type of lymphoma called Diffuse Large B-cell Lymphoma (DLBCL) who haven't had treatment before. Researchers want to see if this new combination works better.